- Lobbying
- Lobbying by Teva Pharmaceuticals USA, Inc.
Lobbying Relationship
Bills mentioned
S.515: Patent Reform Act of 2009
Sponsor: Patrick J. Leahy (D-Vt.)
S.610: Patent Reform Act of 2009
Sponsor: Jon Kyl (R-Ariz.)
H.R.1260: Patent Reform Act of 2009
Sponsor: John Conyers Jr. (D-Mich.)
H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act
Sponsor: Henry A. Waxman (D-Calif.)
S.726: Promoting Innovation and Access to Life-Saving Medicine Act
Sponsor: Charles E. Schumer (D-N.Y.)
H.R.1548: Pathway for Biosimilars Act
Sponsor: Anna G. Eshoo (D-Calif.)
S.1213: Patient-Centered Outcomes Research Act of 2009
Sponsor: Max Baucus (D-Mont.)
S.1259: PATIENTS Act of 2009
Sponsor: Jon Kyl (R-Ariz.)
S.1679: Affordable Health Choices Act
Sponsor: Tom Harkin (D-Iowa)
H.R.3200: America's Affordable Health Choices Act of 2009
Sponsor: John D. Dingell (D-Mich.)
H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...
Sponsor: John D. Dingell (D-Mich.)
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
S.1796: America's Healthy Future Act of 2009
Sponsor: Max Baucus (D-Mont.)
H.R.1706: Protecting Consumer Access to Generic Drugs Act of 2009
Sponsor: Bobby L. Rush (D-Ill.)
S.369: Preserve Access to Affordable Generics Act
Sponsor: Herb Kohl (D-Wis.)
S.25: Citizen Petition Fairness and Accuracy Act of 2007
Sponsor: Herb Kohl (D-Wis.)
S.1145: Patent Reform Act of 2007
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.1908: Patent Reform Act of 2007
Sponsor: Howard L. Berman (D-Calif.)
H.R.1432: Preserve Access to Affordable Generics Act
Sponsor: Henry A. Waxman (D-Calif.)
S.3600: Patent Reform Act of 2008
Sponsor: Jon Kyl (R-Ariz.)
S.28: Generics First Act of 2007
Sponsor: Herb Kohl (D-Wis.)
S.1505: Affordable Biologics for Consumers Act
Sponsor: Judd Gregg (R-N.H.)
S.1695: Biologics Price Competition and Innovation Act of 2007
Sponsor: Edward M. Kennedy (D-Mass.)
S.242: Pharmaceutical Market Access and Drug Safety Act of 2007
Sponsor: Byron L. Dorgan (D-N.D.)
S.251: Pharmaceutical Market Access Act of 2007
Sponsor: David Vitter (R-La.)
S.1082: Food and Drug Administration Revitalization Act
Sponsor: Edward M. Kennedy (D-Mass.)
H.R.2900: Food and Drug Administration Amendments Act of 2007
Sponsor: John D. Dingell (D-Mich.)
H.R.1956: Patient Protection and Innovative Biologic Medicines Act of 2007
Sponsor: Jay Inslee (D-Wash.)
H.R.1038: Access to Life-Saving Medicine Act
Sponsor: Henry A. Waxman (D-Calif.)
H.R.5629: Pathway for Biosimilars Act
Sponsor: Anna G. Eshoo (D-Calif.)
H.R.3610: Food and Drug Import Safety Act of 2007
Sponsor: John D. Dingell (D-Mich.)
H.R.3624: Consumer Food Safety Act of 2007
Sponsor: Frank Pallone (D-N.J.)
H.R.6331: Medicare Improvements for Patients and Providers Act of 2008
Sponsor: Charles B. Rangel (D-N.Y.)
H.R.3161: Agriculture, Rural Development, Food and Drug Administration, and...
Sponsor: Rosa DeLauro (D-Conn.)
S.1859: Agriculture, Rural Development, Food and Drug Administration, and...
Sponsor: Herb Kohl (D-Wis.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Chuck Jones | Legislative Asst - Office of Senator Tom Carper Legislative Asst. - Office of Senator Tom Carper |
Martin Paone | Secretary of the US Senate Secretary for the Majority - US Senate |
Daniel Shapiro | Deputy COS - Office of Sen. Bill Nelson |
Michael J Bates | n/a |
Bryce L Harlow | n/a |
John J Kelliher | n/a |
Ginger Loper | n/a |
Richard J Tarplin | n/a |
Michelle Bright | n/a |
Erin Graefe | n/a |
Marty Paone | n/a |
William E Timmons Jr. | n/a |
William E Timmons Sr. | n/a |
Michael J. Bates | n/a |
Bryce L. Harlow | n/a |
William E. Timmons Sr. | n/a |
William E. Timmons Jr. | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate